Sign Up to like & get
recommendations!
1
Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-114784
Abstract: Rationale: KMT2A-rearrangements (KMT2A-r) in acute myeloid leukemia (AML), encompassing both KMT2a-fusions (KMT2A-F) and KMT2A-partial tandem duplications (KMT2A-PTD), represent a subgroup of AML with a particularly poor prognosis. Both KMT2A-F and KMT2A-PTD share a dependency on…
read more here.
Keywords:
methylation;
midh1;
h3k79 methylation;
kmt2a ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Blood advances"
DOI: 10.1182/bloodadvances.2020001922
Abstract: Understanding mechanisms of cooperation between oncogenes is critical for the development of novel therapies and rational combinations. Acute myeloid leukemia (AML) cells with KMT2A-fusions and KMT2A partial tandem duplications (KMT2APTD) are known to depend on…
read more here.
Keywords:
methylation;
patterns h3k79;
methylation influence;
interaction ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24021387
Abstract: Methylation of histone 3 at lysine 79 (H3K79) and its catalyst, a disrupter of telomeric silencing (DOT1l), have been coupled to multiple forms of stress, such as bioenergetic and ER challenges. However, studies on H3K79…
read more here.
Keywords:
brain aging;
dot1l;
methylation;
h3k79 methylation ... See more keywords